Market Research Reports

Saturday 6 July 2019

Infection Control Market Trend Analysis | Supply and Segmentation | Forecast To 2023

Global Infection Control Market has been segmented on the basis of type and end-user. On the basis of type, the global infection control market can be segmented into disinfection products, sterilization products and services, and others. Disinfection products are categorized into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors. Disinfectants are categorized into type, formulation, and EPA classification.

Disinfectants by type are classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The disinfectant by formulation is categorized into disinfectant wipes, disinfectant liquids, and disinfectant sprays. The EPA classification is categorized into low-level disinfectants, intermediate-level disinfectants, and high-level disinfectants.

Request Free Sample Report @ https://www.marketresearchfuture.com/sample_request/5901

Medical nonwovens are classified into surgical drapes, surgical gowns, sterilization wraps, and face masks. Disinfectors are classified into washer disinfectors, flusher disinfectors, and UV ray disinfectors. The endoscope reprocessors are classified into automated endoscope reprocessors, endoscope tracking systems, and other endoscopic reprocessing products.
Sterilization products and services are classified into sterilization equipment, contract sterilization services, by type, and consumables and accessories.

Sterilization equipment are segmented into heat sterilization equipment, low-temperature sterilization, filtration sterilization, and radiation sterilization. Heat sterilization equipment are categorized into moist heat sterilizers and dry heat sterilizers. The low-temperature sterilization is categorized into Ethylene Oxide Sterilizers (EtO), hydrogen peroxide sterilizers, ozone sterilizers, formaldehyde sterilizers, and other low-temperature sterilization.

Contract sterilization services, by type are segmented into Ethylene Oxide Sterilization (EtO) services, gamma sterilization services, e-beam sterilization services, steam sterilization services, and other contract sterilization services.

Consumables and accessories are segmented into sterilization indicators, sterilant cassettes, and other consumables and accessories.

On the basis of end-user, the global infection control market is segmented into hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others.

The global Infection Control Market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

America

The Americas dominated the global infection control market owing to the constant technological innovations due to the increasing competitiveness among the key players to ensure proper sterilization and disinfection, growing demand for infection control products and services for minimizing the prevalence of Hospital Acquired Infections (HAIs), and increasing number of surgical procedures in the region.

European
The European region is the second largest market for global infection control due to the adoption of new therapies, skilled medical professionals, and availability of advanced treatment facilities.

The increase in awareness of infections and other diseases coupled with the aging population and the penetration of key players in the region are factors that drive the market growth of infection control in emerging countries of Asia Pacific. Besides, the growing initiatives of World Health Organization (WHO) in countries such as India, China, and Japan are likely to foster the strengthening of major Asian countries in the future.

Middle East and Africa
The Middle East and Africa is projected to show steady growth in this market due to the increasing prevalence of infectious diseases along with the demand for diagnosis of infections in remote areas.

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/infection-control-market-5901

Key Players

Some of the key players in the global infection control market are

STERIS Corporation (U.K.),
Getinge Group (Sweden),
Cantel Medical Corporation (U.S.),
Ecolab (U.S.), 3M Healthcare Company (U.S.),
Sotera Health (U.S.),
Advanced Sterilization Products (U.S.),
MMM Group (Germany),
Matachana (Spain),
Belimed AG (Switzerland),
Halyard Health (U.S.),
Metrex Research (U.S.),
Reckitt Benckiser (U.K.),
Pal Internation (U.K.),
Nordion, Inc. (U.S.),
Ahlstrom Corporation (Finland),
Honeywell International, Inc. (U.S.)

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Small Animal Imaging Market SWOT Analysis | Capacity and Opportunities | Forecast To 2023

Global Small Animal Imaging Market Analysis by Key Players, Segmentation, SWOT Analysis, Size, Share, Emerging Trends, Future Outlook, Applications, Insights, Profile, Future Outlook with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2023

Small Animal Imaging is a technique for imaging biological and molecular processes in the small animals using imaging modalities and reagents. This technique can provide valuable information in the preclinical stage or phase I stage of clinical trials. The increase in research funding, rising demand for non-invasive small animal imaging techniques, and technological developments drive the growth of global small animal imaging market.

Request Free Sample Report @ https://www.marketresearchfuture.com/sample_request/6175

Moreover, the rising gene expression studies, increasing drug development activities and increasing government initiatives for research are likely to fuel the market growth during the forecast period. For instance, according to the Federal Funding for Biomedical and Related Life Sciences Research, 84% of the National Health Institutes (NIH) funding is distributed through 60,000 researchers to conduct various research and developments in life science sector. Additionally, according to (FASEB), NIH required a minimum of USD 35.0 billion for life science researches for the year 2017.

Despite the drivers, stringent government regulations regarding animal usage in experiments, the high cost of installation and operation of imaging devices may hamper the growth of global small animal imaging market.

Regional Analysis

America
The Americas is likely to dominate the global small animal imaging market during the forecast period. The market growth is attributed to increasing investments by clinical research organizations in pre-clinical studies, increasing government funding’s in research activities and increasing number of pharmaceutical and research-based organizations.

Europe
Europe is the second largest market in the global small animal imaging market. The European market is expected to grow during the forecast period owing to increasing R&D investments by pharmaceutical companies and growing number of research organizations for diagnosis of diseases. Asia Pacific is expected to be the fastest growing market owing to the increasing government support for biotechnology and pharmaceutical R&D and growing number of translational research activities.

Middle East and Africa
The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and low government support. In this region, the Middle East holds the largest market owing to the development of healthcare infrastructure.

Segmentation
The global small animal imaging market is segmented on the basis of the modality and reagents.
On the basis of the modality, the market is classified into

optical imaging systems,
nuclear imaging systems,
micro-MRI systems,
micro-ultrasound systems,
micro-CT systems,
photoacoustic imaging systems,
Magnetic Particle Imaging (MPI) systems.

The optical imaging systems are further segmented into

bioluminescence/ fluorescence imaging systems,
standalone fluorescence imaging systems,
optical + X-Ray/optical + CT systems.

The nuclear imaging systems are segmented into

micro-Pet systems, micro-spect systems,
trimodality (spect/pet/CT) systems.

The micro-pet system is further segmented into standalone

pet systems, pet/CT system,
pet/MRI systems.

The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.

On the basis of reagent, the market is segmented as

optical imaging reagents,
nuclear imaging reagents,
MRI contrast agents,
ultrasound contrast agents,
CT contrast agents.

The optical imaging reagents are further segmented as

bioluminescent imaging reagents
fluorescent imaging reagents.

The bioluminescent imaging reagents are further segmented into

luciferins,
pro-luciferins,
coelenterazine,
bioluminescent imaging reagents.

The fluorescent imaging reagents are further segmented as

green fluorescent proteins,
red fluorescent proteins,
infrared dyes,
fluorescent imaging reagents.

The nuclear imaging reagents are segmented into

pet tracers
spect probes.

The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes.

The spect probes are further segmented into

technetium-99m-based small animal spect probes,
iodine-131-based small animal spect probes,
gallium-67-based small animal spect probes,
thallium-201-based small animal spect probes,
spect probes.

The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/small-animal-imaging-market-6175

Key Players

Some of the key players in the global small animal imaging market are

PerkinElmer Inc. (U.S.)
Bruker Corporation (U.S.),
FUJIFILM Holdings Corporation (Japan),
Mediso Ltd. (Hungary),
MILabs B.V. (Netherlands),
MR Solutions Ltd. (U.K.),
Aspect Imaging (Israel),
LI-COR Biosciences (U.S.),
Trifoil Imaging (U.S.),
Miltenyi Biotec GmbH (Germany).

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Clinical Laboratory Services Market Insights | Dynamics and Growth | Forecast To 2023

Global Clinical Laboratory Services Market has been assessed to reach a valuation of more than USD 274,400 million at a substantial CAGR by the end of the forecast period. The Global Clinical Laboratory Services Market is Expected to Showcase Exponential Growth Over the Forecast Period of 2018 to 2023, owing to influential factors such as the rising healthcare expenditure globally, and the growing awareness about advanced global clinical laboratory services.

The increased occurrence of chronic and infectious diseases such as diabetes, cancer, cardiovascular disorders, liver & kidney disorders, blood disorders, among others, have risen the global demand for improved diagnostics for the early disease detection.

Request Free Sample Report @ https://www.marketresearchfuture.com/sample_request/7145

Segmental Analysis

The Global Clinical Laboratory Services Market has been segmented on the basis of

type,
application,
region.

Based on type, the global clinical laboratory services market has been segmented into

biochemistry,
endocrinology,
hematology,
microbiology,
histopathology,
cytology,
genetic testing,

Among these, the hematology segment is assessed to show the highest market growth over the forecast period, due to the high prevalence of blood cancer. Additionally, biochemistry segment and the genetic testing segment are estimated to grow at a comparatively higher CAGR due to the high demand for chemistry testing due to the wide range of diagnosis offered through biochemistry testing. Additionally, technological advances in genetic testing are estimated to influence market growth over the forecast period.

Based on application, the clinical laboratory services market has been segmented into

independent,
laboratory,
reference laboratory,
hospital laboratory.

Among these, the hospital laboratory segment is assessed to contribute substantially to the market share due to the wide-ranging services provided by hospital laboratories, and the alarming rise in the prevalence of infectious diseases has risen the demand for early disease detection and is assessed to reach a valuation of USD 185,982 million by the end of the forecast period.

Additionally, independent laboratories are also estimated to grow at a higher CAGR over the forecast period, owing to the increase in initiatives by significant market players to introduce innovative solutions for effective disease detection.

Based on the region, the Global Clinical Laboratory Services Market has been segmented into North America & Latin America, Europe, Asia Pacific, the Middle East & Africa.

Key Players

Spectra Laboratories Inc (U.S.),
Mayo Medical Laboratories (U.S.),
Bio-Reference Laboratories (U.S.),
Clinical Reference Laboratory (U.S.),
ACM Medical Laboratory (U.S.),
Lifelabs Medicals Laboratories (Canada),
Cerba Healthcare Quest Diagnostics Incorporated (France),
Amedes Holdings (Germany),
Synlab International (Germany),
Eurofins Scientific (Luxembourg),
Unilabs (Switzerland),
Sonic Healthcare (UK),
Adicon Clinical Laboratory (China).

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-services-market-7145

Regional Analysis

North America

The North American region is the dominant market for clinical laboratory services globally and is estimated to sustain its leading market share over the forecast period, owing to the presence of major market players that provide advanced test solutions, the rise in chronic diseases prone elderly population, along with the increasing prevalence of diseased associated with urban lifestyle.

Europe

Europe is the second largest regional market for clinical laboratory services, due to the alarming rise in cardiovascular diseases and infectious diseases leading to an increase in the patient population and consequent demand for clinical laboratory services. Europe is estimated to rise at a moderate CAGR and showcase substantial growth over the forecast period.

Asia Pacific

Asia Pacific region is predicted to be a lucrative market for clinical laboratory services due to the substantial investment towards improving the healthcare sector, technological advancements towards testing equipment to provide better facilities to consumers, followed by the rising demand for early diagnosis by consumers.

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Healthcare BPO Market Size | Trends and Share | Forecast To 2023

The pharmaceutical services segment held the maximum share of the market in 2016 and is estimated to register a CAGR of 12.4% during the forecast period. The segment is poised to grow from USD 125,849.8 Mn in 2016 to USD 329,000.3 Mn by 2023.

Market Research Future (MRFR)’s latest study reveals that the global Healthcare BPO Market is projected to thrive exponentially striking a CAGR of 12.3% during the forecast period 2017 to 2023. The market is projected to reach a valuation of USD 449,623.8 Mn by 2023-end up from USD 199,533.8 Mn in 2017. The accelerating revenue from the healthcare sector coupled with the increasing demand from fast-developing economies is anticipated to catalyze the expansion of the healthcare BPO market.

The enormous costs associated with the healthcare facilities remain a challenge to the industry leaders. Thus, a shift towards outsourcing has been witnessed for bringing health care costs down by 30% to 60%, and it is likely to continue through the review period. Furthermore, outsourcing ensures operational efficiency by professionals which is expected to passively fuel demand in the market. Nevertheless, increasing complaints regarding poor BPO services are estimated to slow down the rate of growth by 0.5% to 1% in the foreseeable future.

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1335

Loss of revenue due to poor billing practices and maintenance are the key areas of focus in the healthcare sector. According to a published research report, a loss of USD 125 Bn is incurred every year due to inefficient billing practices. It has intensified the demand for the adoption of BPO in the healthcare sector globally. The trend is poised to perpetuate through the assessment period.

Global Healthcare BPO Market Segmentation

MRFR’s report offers a detailed segmental analysis of the market on the basis of services.

By services, the global healthcare BPO market has been segmented into

pharmaceutical services,
payer services,
provider services.

The pharmaceutical services segment is sub-segmented into

research and development,
manufacturing,
non-clinical Services.

The payer services segment has been sub-segmented into

claim management, member management,
provider management, care management
product development & business acquisition.

The provider services segment is further sub-segmented into

medical billing,
medical coding,
medical transcription,
finance & accounts.

Healthcare BPO Market Regional Outlook:

By region, the healthcare BPO market has been segmented into

Americas,
Europe,
Asia Pacific, and the
Middle East & Africa.

Americas
Americas hold a significant share of the global healthcare BPO market. It is likely to exhibit substantial growth over the next couple of years. The factors such as rising healthcare expenditure, technological advancements, increasing health awareness about healthcare facilities, etc. have augured well for the market players. Additionally, the presence of key players and its strategies for gaining traction in the market are poised to have a positive influence on the expansion of the regional market. The region is well equipped for the adoption of the latest technologies, which when coupled with government support is projected to lead the growth of the market.

Browse Full Research Report at: https://www.marketresearchfuture.com/reports/healthcare-bpo-market-1335

Europe

Europe is expected to remain a highly lucrative market through the projection period. The growth is mostly attributable to the high expenditure in the healthcare sector. According to a report published by OECD, in 2014, the healthcare expenditure of Germany accounted for EUR 321 Bn, trailed by France whose healthcare expenditure was valued at EUR 237 Bn. The market in Europe resonates strong growth opportunities due to the firm support provided by the governments and the availability of funds for the development of the facilities. The regional market in Europe is further sub-segmented into Western and Eastern Europe. Western Europe is set to exhibit a relatively higher CAGR during the assessment period.

Asia Pacific

Asia Pacific is projected to thrive at a relatively higher CAGR. The factors responsible for catapulting the market on an upward trajectory are rapidly evolving healthcare sector, opportunities present for the development of this market, developing healthcare industries & organizations, and improving technology. According to the World Health Organization (WHO), the per capita health care expenditures in Australia and Japan were USD 6,110 and USD 3,966 in 2013. Additionally, healthcare spending in China is expected to grow at a rate of 8.8% during 2015-2018. The trend is likely to continue and benefit the proliferation of the healthcare BPO market in Asia Pacific.

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Pacemaker Market Share | Growth and Size | Forecast To 2023

The global Pacemaker Market is expected to strike a CAGR of 6.5% over the forecast period of 2018-2023, as per the latest study report by Market Research Future (MRFR). Pacemakers regularize heart rhythm by sending electric pulses to the heart and help in restoring cardiac activity. The surge in the prevalence of cardiac diseases has generated high demand for pacemakers which is driving the growth of the global pacemaker market. Atrial fibrillation, in particular, has witnessed a higher incidence rate in recent years which requires pacemakers for remediation. Increase in global geriatric population is also creating a conducive environment for the growth of the market. Atrial fibrillation and cardiac diseases are more prevalent in old patients. As per a 2018 study published in the Aging Medicine, there is 5 to 9% chance of occurrence of atrial fibrillation in patients between the age of 60-80 years and nearly 10% in patients aged over 80 years.

Technological advancements have resulted in the development of advanced pacemakers which are smaller in size and have longer battery life. Other factors aiding the growth of the market include an elevated level of awareness regarding cardiovascular diseases, improvement in reimbursement scenario, and high healthcare expenditure across the globe.

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1587

In recent years, various new pacemakers have received clearance from regulatory bodies which also has augmented the growth of the global pacemaker market. However, the approval and marketing if pacemakers are regulated by the US FDA which are stringent considering the degree of risk they pose to patients. Such stringent regulatory requirements might impede the growth of the market. High costs of pacemakers, risks involved in implantation procedures and risks of malfunctioning are other possible bottlenecks.

Segmentation

The global pacemaker market has been segmented based on product type, application, implant approach, and end-user.

By product type, the global pacemaker market has been segmented into

implantable
external.

The implantable segment has been further segmented into

single chamber,
dual chamber
biventricular.

By application, the global pacemaker market has been segmented into

bradycardia,
heart failure,
hypertrophic cardiomyopathy,
syncope

The bradycardia segment has been further segmented into sinus node dysfunction and AV block.
By implant approach, the global pacemaker market has been segmented into

endocardial approach
epicardial approach.

By end-user, the global pacemaker market has been segmented into

hospitals & clinics,
ambulatory
surgical centers,
research & academic institutes

Regional Analysis

By region, the global pacemaker market has been segmented into the

Americas,
Asia Pacific (APAC),
Europe
Middle East & Africa (MEA).

Americas
The Americas account for the largest share of the global pacemaker market. Presence of a robust healthcare sector and technological advancements accelerate the growth of the market. The FDA has also been approving various novel pacemakers in the region. Moreover, the presence of various medical device manufacturers and surging cases of cardiovascular disorders support market growth in the Americas.

Europe
Europe follows the Americas closely and ranks second in the global pacemaker market. Growing government support in the form of R&D grants and the growing presence of key players in the region drive the market in Europe. The growing incidence rate of cardiovascular diseases and high healthcare expenditure are other factors substantiating the growth of the market.

APAC
APAC pacemaker market is driven by the growing prevalence of atrial fibrillation in the region. In addition, the region has emerged as a medical tourism hub which is likely to propel the growth of the market. Increasing healthcare expenditure and the presence of a large pool of cardiac patients also will have a positive impact on market growth.

MEA

The MEA market is likely to exhibit sluggish growth due to lack of healthcare infrastructure, lack of technical knowledge and less awareness regarding cardiac medical conditions.

Browse Full Research Report at: https://www.marketresearchfuture.com/reports/pacemaker-market-1587

Competitive Landscape

ZOLL Medical Corporation,
MEDICO S.p.A,
Cordis, Inc.,
St. Jude Medical Inc.,
Biotronik GmbH & Co. KG,
Boston Scientific Corporation,
General Electric Company,
Pacetronix,
Medtronic Plc,
Sorin Group,
Edwards Lifesciences,
Cook,
Vitatron

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Cannula Market Profile | Demand, Cost and Profit | Forecast To 2023

global Cannula Market Anticipated to expand at a CAGR of 6.7% Over the Forecast Period. The exponentially rising geriatric population is expected to reflect on the growth pattern of the healthcare sector. It is further expected to have a positive influence on the expansion of the cannula market in the forthcoming years. On the flip side, the factors such as lack of trained physicians and the implementation of strict regulations are anticipated to restrict market expansion over the next couple of years.

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/6937

Market Research Future (MRFR) has projected in its latest report that the global Cannula Market, valued at USD 113 Mn in 2017. A cannula is a hollow retractable tube which is used for removal or delivery of fluids through insertion into vein, arteries or other body cavities. Increasing healthcare services centers in conjunction with the rising patient population is expected to favor market growth in the years to come.

The rising incidences of life-threatening diseases such as cancer, liver cirrhosis, cardiovascular diseases, diabetes, etc. have led to an exponential rise in the demand for medical facilities. The advanced nature of these diseases has led to an increase in demand for long-term or lifetime access to healthcare services. This, in turn, is forecasted to augment the global cannula market over the next couple of years.

Competitive Dashboard:

The prominent players of the global cannula market profiled in this MRFR report are

Medtronic,
Terumo Cardiovascular Systems Corporation,
Edwards Lifesciences Corporation,
LivaNova PLC, Smith & Nephew,
Smiths Medical,
CONMED Corporation,
Teleflex Incorporated,
McKesson Medical-Surgical Inc.,
Boston Scientific Corporation,
Harsoria Healthcare Pvt. Ltd.,
ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA),
ISPG Inc.,
Denex International.

Market Segmentation:

By application, the global cannula market has been segmented into

cardiovascular surgery,
oxygen therapy,
general surgery,
cosmetic/plastic surgery,
orthopedic surgery

By end-user, the cannula market has been segmented into

hospitals,
ambulatory surgical center

By product, the global cannula market has been segmented into

cardiac cannulas,
nasal cannulas,
vascular cannulas,
dermatology cannulas,
arthroscopy cannulas

By material, the cannula market has been segmented into

plastic (PVC),
silicone
metal (stainless steel).

Regional Analysis:

By region, the global cannula market has been segmented into

Americas,
Europe,
Asia Pacific,
Middle East & Africa (MEA).

Browse Full Research Report at: https://www.marketresearchfuture.com/reports/cannula-market-6937

Americas
The report indicates that the global marketplace is set to be dominated by North America over the assessment period. Increasing healthcare expenditure in conjunction with rising demand for medical services is poised to revolutionize the growth trajectory of the cannula market in the region. Furthermore, the presence of developed healthcare infrastructure is poised to have a favorable impact on the expansion of the regional market.

Europe
Europe is expected to hold the second position through the forecast period, and its growth can be ascribed to the accelerated research & development activities. Asia Pacific is likely to exhibit the fastest growth due to the presence of a huge patient population in the region. It is also projected to benefit from advancements in healthcare services in the region.

MEA is prognosticated to hold the least share of the market during the projection period.

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future

Breast Biopsy Market Segmentation | Outlook and Application | Forecast To 2023

There are various types of biopsy procedures that are used depending upon the different techniques like vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). These are recommended by the doctor based on the size, location, and other characteristics of the breast abnormality. The global Breast Biopsy Market is expected to expand in significant fashion during the forecast period of 2018 to 2023. A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body. Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer. This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement.

This includes the infection risks associated with breast biopsy procedures, unspecified regulatory issues, and ambiguous reimbursement policies. In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them. At the same time, the emergence of technologically advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds. The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market. However, there are various constraints limiting the breast biopsy market growth as well.

Request Free Sample Report @ https://www.marketresearchfuture.com/sample_request/6288

Breast Biopsy Market Segmentation

The global breast biopsy market segmentation is done as per technique type, product, guidance technology, and end-user.
By guidance technology, the market includes

CT-guided biopsy,
ultrasound-guided,
mammography-guided magnetic resonance,
image-guided breast biopsy (PET and thermography).

By end-user, the market comprises of

ambulatory surgical centers
hospitals, diagnostic centers

By product, the market includes biopsy tables,

guidance systems,
biopsy needles,
biopsy wires

By technique type, the market includes

core needle biopsy,
fine needle aspiration biopsy,
wire localization,
MRI-guided core needle biopsy,
biopsy markers,
surgical biopsy,
sentinel node biopsy.

The core needle biopsy segment is further segmented into

vacuum-assisted biopsy,
stereotactic core needle biopsy,
ultrasound-guided core biopsy,
freehand core-needle biopsy.

The surgical biopsy segment is divided into excisional biopsy and incisional biopsy.

Breast Biopsy Market Landscape

The global breast biopsy market includes a number of leading market players, including

Cook Medical Incorporated,
Dickinson and Company,
NuVue Therapeutics,
Argon Medical Devices, Inc.,
Johnson & Johnson,
Encapsule Medical Devices LLC.,
Leica Biosystems,
C.R. Bard Inc.,
Argon Medical Devices,
Hologic Inc.,
Devicor Medical Products Inc.,
Becton,
Hologic Inc.,
Karl Storz GmbH & Co. Kg,
GE Healthcare.,
Intact Medical Corporation,
Conceptus INC, and Galini SRL.

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288

Breast Biopsy Market Regional Analysis

The geographical breast biopsy market segmentation covers four major regions, namely

North America,
Asia-Pacific,
Europe, and the
Middle East & Africa.

North America

North America is anticipated to hold the largest market share over the forecast period as per the market report published by MRFR. This is primarily due to the early adoption of advanced medical technologies and a continued emphasis on the development from companies operating in cancer diagnostics.

Europe

The Europe market holds the second-largest share of the breast biopsy market due to the striking prevalence of breast cancer in the UK and Belgium. Both North America and Europe comprise more than 50% of the of the global breast biopsy market share.

Asia-Pacific

The regional market of Asia-Pacific is also slated to experience a period of growth in the forthcoming years. This is because of the demand for advanced technology, better rate of adoption of such technologies, access to optimal treatment facilities, increasing favorable initiatives undertaken by the government, and rising healthcare expenditure.

Middle East & Africa

Lastly, the Middle East & Africa region is expected to garner the least market growth due to the presence of an underdeveloped healthcare industry, poor medical facilities, and lack of technical proficiency and knowledge concerning the operation.

Brows More Healthcare Related Research Reports:

For more details please visit @ Market Research Future